UNSPSC 85522803: Revision of intraluminal device in upper vein, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of intraluminal device in upper vein, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WY0DZ

UNSPSC 85522803 Revision of intraluminal device in upper vein, open approach (Commodity) shows no meaningful recent state and local procurement activity aligned with its clinical scope. The six recent opportunities posted across Arizona, California, Washington State, Texas, and Florida under this code cover independent medical evaluation services for disability retirement determinations, surgical benefit carve-out program management, occupational medical surveillance, specialty and emergency care for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involve intraluminal device revision or vascular intervention. The mismatch between the code's nominal procedural description and the scope of work actually being solicited indicates that state and local procurement offices have tagged medical services opportunities with this Commodity code without regard to its intended clinical meaning.

The issuing bodies—city retirement offices, municipal procurement bureaus, state transportation departments, county health systems, and county commissioners—are acquiring administrative health services, benefits management, and staffing capabilities rather than medical devices or surgical procedures. The lack of device procurement, implant vendors, or surgical supply chain activity under this code suggests it is either misapplied to these opportunities or inactive in state and local purchasing altogether. Vendors evaluating entry into this code territory should confirm category alignment with individual issuing bodies before pursuing opportunities, as the current posting pattern does not support a coherent market signal for intraluminal device-related work.